Furthermore, we demonstrated that EpCAM promoted lung cancer cells invasion and migration, and the impaired tumor cell invasion and migration abilities following MTA1-silenging can be rescued by overexpressing EpCAM. The gene discussed is MTA1; the disease is lung carcinoma.